Pacific Biosciences of California, Inc. Amortization of Intangible Assets
Pacific Biosciences of California, Inc. (PACB) reported Amortization of Intangible Assets of $1.02 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-05-08
- Pacific Biosciences of California, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $1.02M, a 99.72% decline year-over-year.
- Pacific Biosciences of California, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $1.02M, a 85.13% decline year-over-year.
- Pacific Biosciences of California, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $1.02M, a 85.11% decline year-over-year.
- Pacific Biosciences of California, Inc. amortization of intangible assets for the quarter ending 2025-06-30 was $1.02M, a 85.13% decline year-over-year.
- Pacific Biosciences of California, Inc. amortization of intangible assets for fiscal 2025 was $369.45M, a 1247.76% increase from fiscal 2024.
- Pacific Biosciences of California, Inc. amortization of intangible assets for fiscal 2024 was $27.41M, a 231.82% increase from fiscal 2023.
- Pacific Biosciences of California, Inc. amortization of intangible assets for fiscal 2023 was $8.26M, a 804.82% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. amortization of intangible assets for fiscal 2022 was $913.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $1.02M 10-Q · filed 2026-05-08 | $2.04M derived: sum of 2 quarters · filed 2026-05-08 | $3.06M derived: sum of 3 quarters · filed 2026-05-08 | $4.08M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2025-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.04M derived: sum of 2 quarters · filed 2026-02-25 | $3.06M derived: sum of 3 quarters · filed 2026-02-25 | $369.45M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.04M derived: sum of 2 quarters · filed 2025-11-06 | $368.43M 10-Q · filed 2025-11-06 | $375.28M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2025-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $367.41M 10-Q · filed 2025-08-07 | $374.26M derived: sum of 3 quarters · filed 2026-05-08 | $381.12M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2025-03-31 | $366.39M 10-Q · filed 2026-05-08 | $373.24M derived: sum of 2 quarters · filed 2026-05-08 | $380.10M derived: sum of 3 quarters · filed 2026-05-08 | $386.95M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $13.71M derived: sum of 2 quarters · filed 2026-02-25 | $20.56M derived: sum of 3 quarters · filed 2026-02-25 | $27.41M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $6.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $13.71M derived: sum of 2 quarters · filed 2025-11-06 | $20.56M 10-Q · filed 2025-11-06 | $27.41M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $6.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $13.71M 10-Q · filed 2025-08-07 | $20.56M derived: sum of 3 quarters · filed 2026-02-25 | $21.50M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $6.85M 10-Q · filed 2025-05-12 | $13.71M derived: sum of 2 quarters · filed 2026-02-25 | $14.65M derived: sum of 3 quarters · filed 2026-02-25 | $14.88M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.79M derived: sum of 2 quarters · filed 2026-02-25 | $8.03M derived: sum of 3 quarters · filed 2026-02-25 | $8.26M 10-K · filed 2026-02-25 | $6.16M 10-K · filed 2024-02-28 |
| 2023-09-30 | $942.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.17M derived: sum of 2 quarters · filed 2024-11-12 | $1.41M 10-Q · filed 2024-11-12 | $1.64M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-06-30 | $232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $466.00K 10-Q · filed 2024-08-09 | $694.00K derived: sum of 3 quarters · filed 2025-03-17 | $923.00K derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-03-31 | $234.00K 10-Q · filed 2024-05-09 | $462.00K derived: sum of 2 quarters · filed 2025-03-17 | $691.00K derived: sum of 3 quarters · filed 2025-03-17 | $919.00K derived: sum of 4 quarters · filed 2025-03-17 | |
| 2022-12-31 | $228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $457.00K derived: sum of 2 quarters · filed 2025-03-17 | $685.00K derived: sum of 3 quarters · filed 2025-03-17 | $913.00K 10-K · filed 2025-03-17 | $900.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $229.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $457.00K derived: sum of 2 quarters · filed 2023-11-03 | $685.00K 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | $228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $456.00K 10-Q · filed 2023-08-04 | |||
| 2022-03-31 | $228.00K 10-Q · filed 2023-05-04 | ||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | $400.00K 10-K · filed 2022-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |